[1]
|
Hertza, J., Loughan, A., Perna, R., Davis, A.S., Segraves, K. and Tiberi, N.L. (2013) Moyamoya Disease: A Review of the Literature. Applied Neuropsychology: Adult, 21, 21-27. https://doi.org/10.1080/09084282.2012.721147
|
[2]
|
Suzuki, J. (1969) Cerebrovascular “Moyamoya” Disease: Disease Showing Abnormal Net-Like Vessels in Base of Brain. Archives of Neurology, 20, 288-299. https://doi.org/10.1001/archneur.1969.00480090076012
|
[3]
|
Kim, T., Lee, H., Bang, J.S., Kwon, O., Hwang, G. and Oh, C.W. (2015) Epidemiology of Moyamoya Disease in Korea: Based on National Health Insurance Service Data. Journal of Korean Neurosurgical Society, 57, 390-395. https://doi.org/10.3340/jkns.2015.57.6.390
|
[4]
|
Piao, J., Wu, W., Yang, Z. and Yu, J. (2015) Research Progress of Moyamoya Disease in Children. International Journal of Medical Sciences, 12, 566-575. https://doi.org/10.7150/ijms.11719
|
[5]
|
Sun, X., Wen, J., Li, J., Lai, R., Wang, Y., Liu, H., et al. (2016) The Association between the Ring Finger Protein 213 (RNF213) Polymorphisms and Moyamoya Disease Susceptibility: A Meta-Analysis Based on Case-Control Studies. Molecular Genetics and Genomics, 291, 1193-1203. https://doi.org/10.1007/s00438-016-1172-5
|
[6]
|
Allarakhia, I. (2013) Pediatric Moyamoya Disease. American Journal of Case Reports, 14, 134-138. https://doi.org/10.12659/ajcr.889170
|
[7]
|
Hishikawa, T., Sugiu, K. and Date, I. (2016) Moyamoya Disease: A Review of Clinical Research. Acta Medica Okayama, 70, 229-236.
|
[8]
|
Zhang, D., Huang, L., Huang, Z., Zhou, Q., Yang, X., Gu, H., et al. (2022) Epidemiology of Moyamoya Disease in China: A Nationwide Hospital-Based Study. The Lancet Regional Health—Western Pacific, 18, Article ID: 100331. https://doi.org/10.1016/j.lanwpc.2021.100331
|
[9]
|
Birkeland, P., Tharmabalan, V., Lauritsen, J., Ganesan, V., Bjarkam, C.R. and von Weitzel‐Mudersbach, P. (2020) Moyamoya Disease in a European Setting: A Danish Population‐Based Study. European Journal of Neurology, 27, 2446-2452. https://doi.org/10.1111/ene.14439
|
[10]
|
李万春, 阮世望, 张宪秋, 等. 青少年脑梗死的临床及病因学分析[J]. 中国实用医药, 2009, 4(5): 95-96.
|
[11]
|
王靖阳, 徐强. 中药注射剂治疗脑梗死临床研究进展[J]. 中国中医药现代远程教育, 2024, 22(11): 166-169.
|
[12]
|
周仲瑛. 中医内科学[M]. 第2版. 北京: 中国中医药出版社, 2007: 304-315.
|
[13]
|
付雄洁, 曾翰海, 芦晓阳, 等. 烟雾病和烟雾综合征[J]. 浙江医学, 2017, 39(23): 2175-2178.
|
[14]
|
中华医学会神经外科学分会. 烟雾病和烟雾综合征诊断与治疗中国专家共识(2024版) [J].中华神经外科杂志, 2024, 40(3): 220-229.
|
[15]
|
Scott, R.M. and Smith, E.R. (2009) Moyamoya Disease and Moyamoya Syndrome. New England Journal of Medicine, 360, 1226-1237. https://doi.org/10.1056/nejmra0804622
|
[16]
|
Thines, L., Petyt, G., Aguettaz, P., Bodenant, M., Himpens, F.X., Lenci, H., et al. (2015) Surgical Management of Moyamoya Disease and Syndrome: Current Concepts and Personal Experience. Revue Neurologique, 171, 31-44. https://doi.org/10.1016/j.neurol.2014.08.007
|
[17]
|
岳建和, 张晓林, 吉翔, 等. 联合搭桥手术治疗烟雾病的手术时机和疗效的相关性研究[J]. 第三军医大学学报, 2020, 42(3): 294-299.
|
[18]
|
Takahashi, J.C., Funaki, T., Houkin, K., Kuroda, S., Fujimura, M., Tomata, Y., et al. (2021) Impact of Cortical Hemodynamic Failure on Both Subsequent Hemorrhagic Stroke and Effect of Bypass Surgery in Hemorrhagic Moyamoya Disease: A Supplementary Analysis of the Japan Adult Moyamoya Trial. Journal of Neurosurgery, 134, 940-945. https://doi.org/10.3171/2020.1.jns192392
|
[19]
|
陈夫涛, 高佩虹, 贾春雪, 等. 高分辨磁共振成像技术在颅内动脉狭窄性疾病中的应用[J]. 医学综述, 2020, 26(3): 565-570, 576.
|
[20]
|
李旭辉, 赵宁辉. 烟雾病的诊疗进展[J]. 云南医药, 2014(5): 583-585.
|
[21]
|
烟雾病治疗中国专家共识编写组. 烟雾病治疗中国专家共识[J]. 国际脑血管病杂志, 2019, 27(9): 645-650.
|